Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SORT OUT XII DAPT Duration Trial
NCT06718179Phase 4Terminated
- Sponsor
- University Hospital Odense
- Start
- Nov 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel and aspirin in acute coronary syndrome (ACS) (2 arms), sponsored by University Hospital Odense. Primary endpoints: Number of patients with clinically relevant bleeding at 1 year and Number of patients with a composite major adverse cardiovascular or cerebrovascular events at 1 year. Started Nov 2024; status: terminated.
02
Drugs
prasugrelaspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06718179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06718179.